| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
10,483 |
7,970 |
$1.72M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,083 |
3,173 |
$42K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
968 |
879 |
$22K |
| 85018 |
|
1,768 |
1,514 |
$18K |
| 90686 |
|
648 |
570 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,200 |
1,040 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
859 |
682 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
646 |
572 |
$7K |
| 96127 |
|
1,916 |
1,555 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
562 |
483 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
446 |
377 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
36 |
34 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
64 |
63 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
75 |
73 |
$898.30 |
| 90649 |
|
33 |
33 |
$581.92 |
| 99173 |
|
14 |
14 |
$290.96 |
| 92551 |
|
14 |
14 |
$290.96 |
| 0071A |
|
38 |
31 |
$280.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
39 |
38 |
$88.33 |
| 0072A |
|
18 |
18 |
$80.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,165 |
856 |
$5.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
188 |
148 |
$0.00 |
| 90670 |
|
28 |
28 |
$0.00 |
| 90734 |
|
20 |
20 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 3078F |
|
44 |
44 |
$0.00 |
| 90658 |
|
12 |
12 |
$0.00 |
| 81002 |
|
23 |
22 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
29 |
14 |
$0.00 |
| 90480 |
|
15 |
13 |
$0.00 |
| 90656 |
|
14 |
14 |
$0.00 |
| 3074F |
|
44 |
44 |
$0.00 |
| 3008F |
|
101 |
93 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
168 |
159 |
$0.00 |
| 90688 |
|
148 |
147 |
$0.00 |
| 87428 |
|
38 |
38 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
209 |
152 |
$0.00 |
| 90619 |
|
17 |
13 |
$0.00 |
| 1036F |
|
13 |
13 |
$0.00 |